#Macrophage κ‑OR mitigates #hypoxic #PulmonaryHypertension by upregulating SCD1, suppressing macrophage inflammation, and limiting smooth muscle proliferation, underscoring κ‑OR activation as a therapeutic strategy for #rightheartdysfunction.
#OpenAccess: doi.org/10.1016/j.ge...
Macrophage κ-opioid receptor inhibits hypoxic pulmonary hypertension progression and right heart dysfunction via an SCD1-dependent anti-inflammatory response
This new study demonstrates that macrophage κ-opioid receptor (κ-OR) inhibits hypoxic pulmonary hypertension (HPH) and #rightheartdysfunction by up-regulating #SCD1, thereby supporting the potential #therapeutic role of κ-OR activation in the treatment of HPH. #medsky
#OpenAccess: buff.ly/X0ORHCk
Macrophage κ-opioid receptor inhibits hypoxic pulmonary hypertension progression and right heart dysfunction via an SCD1-dependent anti-inflammatory response
This new study demonstrates that macrophage κ-opioid receptor (κ-OR) inhibits hypoxic pulmonary hypertension (HPH) and #rightheartdysfunction by up-regulating #SCD1, thereby supporting the potential #therapeutic role of κ-OR activation in the treatment of HPH.
#OpenAccess: buff.ly/wCZ3D4e